<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - INDOMETACIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>INDOMETACIN</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#conceptionAndContraception" data-toggle="tab">conception and contraception</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pain and moderate to severe inflammation in rheumatic disease and other musculoskeletal disorders</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth using modified-release medicines</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                50&#8211;200 mg daily in divided doses.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                100 mg twice daily if required, dose to be administered at night and in the morning, combined oral and rectal treatment, maximum total daily dose 150&#8211;200 mg.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                75 mg 1&#8211;2 times a day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute gout</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth using modified-release medicines</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                150&#8211;200 mg daily in divided doses.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                75 mg 1&#8211;2 times a day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Dysmenorrhoea</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth using modified-release medicines</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Up to 75 mg daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                75 mg daily.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use or <ph outputclass="route">rectal</ph> use</h3>
              <p>Avoid unless the potential benefit outweighs the risk.</p><p>Avoid during the third trimester (risk of closure of fetal ductus arteriosus <i>in utero</i> and possibly persistent pulmonary hypertension of the newborn); onset of labour may be delayed and duration may be increased.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use or <ph outputclass="route">rectal</ph> use</h3>
              <p>Use with caution; there is an increased risk of gastro-intestinal bleeding and fluid retention.</p><p>Avoid in severe liver disease.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use or <ph outputclass="route">rectal</ph> use</h3>
              <p>The lowest effective dose should be used for the shortest possible duration.</p>
            </section>
        
            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use or <ph outputclass="route">rectal</ph> use</h3>
              <p>Avoid if possible or use with caution.</p><p>Avoid in severe impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>rare:</strong> alveolitis, aseptic meningitis (patients with connective-tissue disorders such as systemic lupus erythematosus may be especially susceptible), blood disorders, confusion, convulsions, hepatic damage, hyperglycaemia, interstitial fibrosis associated with NSAIDs can lead to renal failure, intestinal strictures, pancreatitis, papillary necrosis associated with NSAIDs can lead to renal failure, peripheral neuropathy, psychiatric disturbances, pulmonary eosinophilia, Stevens-Johnson syndrome, syncope, thrombocytopenia, toxic epidermal necrolysis, visual disturbances, alveolitis, aseptic meningitis (patients with connective-tissue disorders such as systemic lupus erythematosus may be especially susceptible), blood disorders, confusion, convulsions, hepatic damage, hyperglycaemia, interstitial fibrosis associated with NSAIDs can lead to renal failure, intestinal strictures, pancreatitis, papillary necrosis associated with NSAIDs can lead to renal failure, peripheral neuropathy, psychiatric disturbances, pulmonary eosinophilia, Stevens-Johnson syndrome, syncope, thrombocytopenia, toxic epidermal necrolysis, visual disturbances,
              </p>
              <p>
                <strong>notKnown:</strong> angioedema, blood disorders, bronchospasm, colitis (induction of or exacerbation of), Crohn&#8217;s disease (induction of or exacerbation of), depression, diarrhoea, dizziness, drowsiness, fluid retention (rarely precipitating congestive heart failure), gastro-intestinal bleeding, gastro-intestinal discomfort, gastro-intestinal disturbances, gastro-intestinal ulceration, haematuria, headache, hearing disturbances, hyperkalaemia, hypersensitivity reactions, insomnia, nausea, nervousness, photosensitivity, raised blood pressure, rashes, renal failure (especially in patients with pre-existing renal impairment), tinnitus, vertigo, angioedema, blood disorders, bronchospasm, colitis (induction of or exacerbation of), Crohn&#8217;s disease (induction of or exacerbation of), depression, diarrhoea, dizziness, drowsiness, fluid retention (rarely precipitating congestive heart failure), gastro-intestinal bleeding, gastro-intestinal discomfort, gastro-intestinal disturbances, gastro-intestinal ulceration, haematuria, headache, hearing disturbances, hyperkalaemia, hypersensitivity reactions, insomnia, nervousness, photosensitivity, raised blood pressure, rashes, renal failure (especially in patients with pre-existing renal impairment), suppositories may cause occasional bleeding, suppositories may cause rectal irritation, tinnitus, vertigo,
              </p>
        
            <section class="advice">
                <h3>Serious side-effects</h3>
              <p>For information about cardiovascular and gastro-intestinal side-effects, and a possible exacerbation of symptoms in asthma, see <xref format="dita" href="#PHP78612" type="bookmark" namespace="/treatment-summaries/non-steroidal-anti-inflammatory-drugs">Non-steroidal anti-inflammatory drugs</xref>.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Heart failure
          </li>
        </ul>
        <ul>
          <li>
              <strong>With oral use:</strong>
            allergic disorders
          </li>
          <li>
              <strong>With oral use:</strong>
            cardiac impairment (NSAIDs may impair renal function)
          </li>
          <li>
              <strong>With oral use:</strong>
            cerebrovascular disease
          </li>
          <li>
              <strong>With oral use:</strong>
            coagulation defects
          </li>
          <li>
              <strong>With oral use:</strong>
            connective-tissue disorders
          </li>
          <li>
              <strong>With oral use:</strong>
            Crohn&#8217;s disease (may be exacerbated)
          </li>
          <li>
              <strong>With oral use:</strong>
            epilepsy
          </li>
          <li>
              <strong>With oral use:</strong>
            ischaemic heart disease
          </li>
          <li>
              <strong>With oral use:</strong>
            peripheral arterial disease
          </li>
          <li>
              <strong>With oral use:</strong>
            psychiatric disturbances
          </li>
          <li>
              <strong>With oral use:</strong>
            risk factors for cardiovascular events
          </li>
          <li>
              <strong>With oral use:</strong>
            ulcerative colitis (may be exacerbated)
          </li>
          <li>
              <strong>With oral use:</strong>
            uncontrolled hypertension
          </li>
          <li>
              <strong>With rectal use:</strong>
            allergic disorders
          </li>
          <li>
              <strong>With rectal use:</strong>
            avoid rectal administration in haemorrhoids
          </li>
          <li>
              <strong>With rectal use:</strong>
            avoid rectal administration in proctitis
          </li>
          <li>
              <strong>With rectal use:</strong>
            cardiac impairment (NSAIDs may impair renal function)
          </li>
          <li>
              <strong>With rectal use:</strong>
            cerebrovascular disease
          </li>
          <li>
              <strong>With rectal use:</strong>
            coagulation defects
          </li>
          <li>
              <strong>With rectal use:</strong>
            connective-tissue disorders
          </li>
          <li>
              <strong>With rectal use:</strong>
            Crohn&#8217;s disease (may be exacerbated)
          </li>
          <li>
              <strong>With rectal use:</strong>
            epilepsy
          </li>
          <li>
              <strong>With rectal use:</strong>
            ischaemic heart disease
          </li>
          <li>
              <strong>With rectal use:</strong>
            peripheral arterial disease
          </li>
          <li>
              <strong>With rectal use:</strong>
            psychiatric disturbances
          </li>
          <li>
              <strong>With rectal use:</strong>
            risk factors for cardiovascular events
          </li>
          <li>
              <strong>With rectal use:</strong>
            ulcerative colitis (may be exacerbated)
          </li>
          <li>
              <strong>With rectal use:</strong>
            uncontrolled hypertension
          </li>
          <li>
              <strong>With systemic use:</strong>
            elderly (risk of serious side-effects and fatalities)
          </li>
          <li>
              <strong>With systemic use:</strong>
            parkinsonism
          </li>
        </ul>
      </section>

      <section class="tab-pane" id="conceptionAndContraception">
        <h2>Advice regarding conception and contraception</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Caution&#8212;long-term use of some NSAIDs is associated with reduced female fertility, which is reversible on stopping treatment.</p>
            </section>
      </section>

      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use or <ph outputclass="route">rectal</ph> use</h3>
              <p>During prolonged therapy ophthalmic and blood examinations particularly advisable.</p>
            </section>
      </section>

      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <p>Use of indometacin in premature labour is an unlicensed indication.</p>
            </section>
      </section>









      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

            <section class="contraindications">
              <p>Contraindicated in patients with a history of hypersensitivity to aspirin or any other NSAID&#8212;which includes those in whom attacks of asthma, angioedema, urticaria or rhinitis have been precipitated by aspirin or any other NSAID.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of INDOMETACIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            oral suspension,
            oral solution,

            <div id="PHP77288"><a href="../medicinalForm/PHP77288.html" data-target="#PHP77288" data-action="load">Capsule</a></div>
            <div id="PHP77295"><a href="../medicinalForm/PHP77295.html" data-target="#PHP77295" data-action="load">Modified-release capsule</a></div>
            <div id="PHP77281"><a href="../medicinalForm/PHP77281.html" data-target="#PHP77281" data-action="load">Suppository</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
